Aethlon Medical, Inc. (AEMD)
NASDAQ: AEMD · Real-Time Price · USD
1.250
-0.690 (-35.57%)
At close: Jun 27, 2025, 4:00 PM
1.180
-0.070 (-5.60%)
After-hours: Jun 27, 2025, 7:59 PM EDT

Aethlon Medical Cash Flow Statement

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2016 - 2020
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2016 - 2020
Net Income
--12.21-12.03-10.42-7.89
Upgrade
Depreciation & Amortization
-0.360.240.120.04
Upgrade
Loss (Gain) From Sale of Assets
-0.020.14--
Upgrade
Stock-Based Compensation
-1.221.050.750.78
Upgrade
Other Operating Activities
-00.020.03-0.01
Upgrade
Change in Accounts Receivable
--0.130.020.06
Upgrade
Change in Accounts Payable
-0.16-0.170.10.34
Upgrade
Change in Unearned Revenue
---0.340.230.01
Upgrade
Change in Other Net Operating Assets
-0.320.46-0.6-0.1
Upgrade
Operating Cash Flow
--10.13-10.51-9.77-6.76
Upgrade
Capital Expenditures
--0.25-0.94-0.35-0.06
Upgrade
Investing Cash Flow
--0.25-0.94-0.35-0.06
Upgrade
Issuance of Common Stock
-1.328.9317.467.26
Upgrade
Repurchase of Common Stock
--0.03-0.01-0.09-0.13
Upgrade
Financing Cash Flow
-1.298.9117.377.13
Upgrade
Foreign Exchange Rate Adjustments
-0-0.01--
Upgrade
Net Cash Flow
--9.09-2.547.250.3
Upgrade
Free Cash Flow
--10.38-11.45-10.12-6.82
Upgrade
Free Cash Flow Margin
---1993.62%-3439.01%-1035.47%
Upgrade
Free Cash Flow Per Share
--33.05-44.59-54.84-45.16
Upgrade
Levered Free Cash Flow
--5.95-7.02-6.22-3.86
Upgrade
Unlevered Free Cash Flow
--5.95-7.02-6.22-3.86
Upgrade
Change in Net Working Capital
-0.38-0.08-0.070.23-0.31
Upgrade
Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q